Authors: Ferris, A Jacobs, T Widlitz, A Barst, RJ Morse, JH

Citation: A. Ferris et al., Pulmonary arterial hypertension and thyroid disease, CHEST, 119(6), 2001, pp. 1980-1981

Authors: Warshofsky, MK Dominguez, M Eisenberg, MS Wasserman, HS Sciacca, R Wang, WZ Simon, AD Morse, JH Schwartz, A Angles-Cano, E Rabbani, LE

Citation: Mk. Warshofsky et al., Elevated plasma tissue plasminogen activator and anti-THP-1 antibodies areindependently associated with decreased graft survival in cardiac transplant recipients, AM J CARD, 88(1), 2001, pp. 30-34

Authors: Deng, ZM Haghighi, F Helleby, L Vanterpool, K Horn, EM Barst, RJ Hodge, SE Morse, JH Knowles, JA

Citation: Zm. Deng et al., Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33, AM J R CRIT, 161(3), 2000, pp. 1055-1059

Authors: Morse, JH Antohi, S Kasturi, K Saito, S Fotino, M Humbert, M Simonneau, G Basst, RJ Bona, CA

Citation: Jh. Morse et al., Fine specificity of anti-fibrillin-1 autoantibodies in primary pulmonary hypertension syndrome, SC J IMMUN, 51(6), 2000, pp. 607-611

Authors: Deng, ZM Morse, JH Slager, SL Cuervo, N Moore, KJ Venetos, G Kalachikov, S Cayanis, E Fischer, SG Barst, RJ Hodge, SE Knowles, JA

Citation: Zm. Deng et al., Familial primary pulmonary hypertension (gene PPH1) is caused by mutationsin the bone morphogenetic protein receptor-II gene, AM J HU GEN, 67(3), 2000, pp. 737-744

Authors: Morse, JH Horn, EM Barst, RJ

Citation: Jh. Morse et al., Hormone replacement therapy - A possible risk factor in carriers of familial primary pulmonary hypertension, CHEST, 116(3), 1999, pp. 847-847